Bayern Munich’s latest picture of Jamal Musiala is more hopeful than Uli Hoeneß’s public remarks suggested. The club still doesn’t know when its attacking midfielder will be ready to play regularly, and the immediate issue is a muscle injury that has interrupted his return to training. But reports say the neurological symptoms that raised concern have been under control for about two months, while the doctors treating him believe he can regain his former level. Those are encouraging signs, though they don’t answer the practical question Bayern needs settled: when can Musiala build up enough training and match fitness to help the team again?
Neurological symptoms reportedly under control
Hoeneß, Bayern’s honorary president, questioned on BR’s Sonntags-Stammtisch whether Musiala would ever reach his previous standard again. His comments reportedly caused frustration inside the club, according to Tz. The underlying concern is understandable: Musiala has been dealing with a health issue as well as an injury, and neither the timeline nor the eventual effect on his football has been established publicly. Still, club figures reportedly felt there was little reason to reopen the question while he was already out with a muscle problem. Public speculation can turn an uncertain recovery into a verdict before the player has had a chance to complete it.
A report from Absolut Bayern, Tz’s Bayern newsletter, says Musiala has had no further episode related to his neurological dysfunction for about two months. His medication has been adjusted, and the doctors treating him remain confident he can return to his previous level. That’s a meaningful update, but it should be read for what it is: a report about current stability and medical confidence, not confirmation that every symptom has disappeared or that a return date has been set. Recovery from a neurological issue can’t be judged from a training clip or a single public appearance. The details matter, and the report doesn’t supply a timetable.
There is a reported trade-off: the medication can temporarily slow Musiala’s play after he takes it. The report also suggests Hoeneß may be weighing the financial stakes. The 23-year-old is reportedly earning up to €25 million a year. That figure may sharpen the attention around his availability, but it doesn’t explain his medical situation or determine how quickly he can return. A player’s value to Bayern is measured partly in wages and squad planning; his recovery still depends on health, careful monitoring and a training load he can tolerate. Here’s the thing: a clear medical plan and a clear football timeline aren’t the same thing.
Muscle injury remains the immediate hurdle
For now, Musiala’s physical recovery is the more immediate concern. He suffered a muscle fiber tear during Germany’s Nations League warm-up against the Netherlands on September 24. He has returned to team training, but the process has had setbacks: Absolut Bayern reports that renewed pain during a conditioning session led Bayern to reduce his workload. That’s a cautious adjustment, and it points to the challenge of rebuilding fitness after an injury without asking too much of a player who is still working his way back. A return to the training ground is progress; it doesn’t automatically mean a player is ready for the speed and repeated effort of a match.
That interruption helps explain why his absence has lasted longer than expected. It also adds context to Lothar Matthäus’ recent questions about the recovery timeline. The report gives no indication that Musiala has suffered another muscle tear. Renewed pain can still affect the schedule even without a new tear, because the club has to judge whether he can increase his workload safely. From the outside, that can look like a recovery that keeps changing direction. In practice, the staff’s willingness to scale training back may be part of managing the uncertainty, rather than evidence that the first injury has been repeated.
For Bayern, the distinction between team training and match readiness is more than semantics. Training allows the club to increase demands in stages and observe how Musiala responds; competitive minutes add a different level of intensity and pressure. The available report doesn’t say when he’ll reach that point, so any firm return prediction would go beyond the information here. If you’re following the situation, the useful signs will be sustained participation and a gradual increase in workload, not simply a single day back with the squad.
Kompany continues to back Musiala
Musiala’s status within the squad appears unchanged. Vincent Kompany continues to see him as Bayern’s decisive attacking presence and has backed him consistently, calling the current version of Musiala the best he has ever seen. That public confidence matters because it gives the player a clear place in the coach’s plans while he works through a difficult stretch. It doesn’t guarantee a smooth recovery, and it can’t tell us how quickly Musiala will be able to produce at his usual level. But it does make clear that his role at Bayern hasn’t been publicly recast because of this absence.
There’s no guarantee the recovery will be straightforward, and Bayern needs its number 10 back on the pitch. The reported stability in Musiala’s neurological symptoms, his doctors’ optimism and Kompany’s continued support offer grounds for a more positive outlook than Hoeneß’s comments conveyed. That said, optimism has to leave room for the interrupted conditioning work and the reported effect of his medication. The next milestone is a steady return to full training and, ultimately, match fitness. Not a date on a calendar.
What the recovery means for Bayern
This is more significant than it looks. Musiala isn’t just a name missing from the team sheet: Kompany has described him as a decisive attacking presence, so his absence changes the options available to Bayern in the final third. The report doesn’t spell out how the club has adapted its tactics, and there’s no need to guess. The plain point is that a player considered central to the coach’s plans can’t be replaced simply by announcing confidence in his recovery. Bayern needs to manage the present while waiting for a dependable return.
The medical and football questions are linked, but they’re not interchangeable. Stable neurological symptoms are reassuring in their own right, while the muscle injury currently governs how much work Musiala can do with the team. Medication that can temporarily slow his play adds another factor for the player and doctors to account for. The report offers no basis for predicting whether that effect will persist or how it will shape his eventual performances. That uncertainty is precisely why the next steps are likely to matter more than broad declarations about whether he’ll be the same player.
For Musiala, the immediate test is whether he can build consistency: more training, then the physical demands of match preparation, with his response monitored along the way. For Bayern, patience has a cost, but so does rushing a player whose return has already been interrupted by pain. And this is the part most people overlook: the most encouraging update may be that the reports describe his symptoms as controlled, while the most actionable update is still the reduction in his training workload. Both can be true at once.
So the outlook is better than Hoeneß’s remarks implied, but it remains conditional. The medical team’s confidence is a reason for cautious optimism, not a promise about timing or performance. Kompany’s backing suggests Musiala’s standing remains strong inside the squad. The next evidence will come from his recovery itself, as he works toward full training and match fitness.
Join the conversation!
Sign up for a user account and get:
- New, improved notifications system!
- Fewer ads
- Create community posts
- Comment on articles, community posts
- Rec comments, community posts